Selected research
Industry Growth & Trends
Global Epigenetics NGS Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Epigenetics NGS Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Epigenetics NGS Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Epigenetics NGS Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Epigenetics NGS Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Epigenetics NGS Service market include Active Motif, Agilent, Zymo Research, Celemics, EpiGentek, GENEWIZ from Azenta, Thermo Fisher Scientific, GenomeScan and Hologic Diagenode, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Epigenetics NGS Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Epigenetics NGS Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Epigenetics NGS Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Epigenetics NGS Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Epigenetics NGS Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Epigenetics NGS Service Market by Company
Active Motif
Agilent
Zymo Research
Celemics
EpiGentek
GENEWIZ from Azenta
Thermo Fisher Scientific
GenomeScan
Hologic Diagenode
Illumina
Macrogen
Novogene
Roche Sequencing Solutions
SeqMatic
Epigenetics NGS Service Segment by Type
DNA Methylation Sequencing
Histone Modification Sequencing
3D Genome Sequencing
Others
Epigenetics NGS Service Segment by Application
Clinical Diagnostics
Basic Research
Drug Development
Agricultural Breeding
Others
Epigenetics NGS Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenetics NGS Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epigenetics NGS Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenetics NGS Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Epigenetics NGS Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Methylation Sequencing
- Histone Modification Sequencing
- 3D Genome Sequencing
- Others
Applications
- Clinical Diagnostics
- Basic Research
- Drug Development
- Agricultural Breeding
- Others
Companies covered
- Active Motif
- Agilent
- Zymo Research
- Celemics
- EpiGentek
- GENEWIZ from Azenta
- Thermo Fisher Scientific
- GenomeScan
- Hologic Diagenode
- Illumina
- Macrogen
- Novogene
- Roche Sequencing Solutions
- SeqMatic
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Epigenetics NGS Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Epigenetics NGS Service Market Size by Region (2021-2032)
- 1.4.1 Global Epigenetics NGS Service Market Size by Region (2021-2026)
- 1.4.2 Global Epigenetics NGS Service Market Size by Region (2027-2032)
- 1.5 Key Regions Epigenetics NGS Service Market Size (2021-2032)
- 1.5.1 North America Epigenetics NGS Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Epigenetics NGS Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Epigenetics NGS Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Epigenetics NGS Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Epigenetics NGS Service Market Size Growth Rate (2021-2032)
2 Epigenetics NGS Service Market by Type
- 2.1 Type Introduction
- 2.1.1 DNA Methylation Sequencing
- 2.1.2 Histone Modification Sequencing
- 2.1.3 3D Genome Sequencing
- 2.1.4 Others
- 2.2 Global Epigenetics NGS Service Market Size by Type
- 2.2.1 Global Epigenetics NGS Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Epigenetics NGS Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Epigenetics NGS Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Epigenetics NGS Service Market Size by Regions
- 2.3.1 North America Epigenetics NGS Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Epigenetics NGS Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Epigenetics NGS Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Epigenetics NGS Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Epigenetics NGS Service Market Size Breakdown by Type (2021-2026)
3 Epigenetics NGS Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinical Diagnostics
- 3.1.2 Basic Research
- 3.1.3 Drug Development
- 3.1.4 Agricultural Breeding
- 3.1.5 Others
- 3.2 Global Epigenetics NGS Service Market Size by Application
- 3.2.1 Global Epigenetics NGS Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Epigenetics NGS Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Epigenetics NGS Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Epigenetics NGS Service Market Size by Regions
- 3.3.1 North America Epigenetics NGS Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Epigenetics NGS Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Epigenetics NGS Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Epigenetics NGS Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Epigenetics NGS Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Epigenetics NGS Service Industry Trends
- 4.2 Epigenetics NGS Service Industry Drivers
- 4.3 Epigenetics NGS Service Industry Opportunities and Challenges
- 4.4 Epigenetics NGS Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Epigenetics NGS Service Revenue (2021-2026)
- 5.2 Global Epigenetics NGS Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Epigenetics NGS Service Key Company Headquarters & Area Served
- 5.4 Global Epigenetics NGS Service Company, Product Type & Application
- 5.5 Global Epigenetics NGS Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Epigenetics NGS Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Epigenetics NGS Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Epigenetics NGS Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Active Motif
- 6.1.1 Active Motif Company Information
- 6.1.2 Active Motif Business Overview
- 6.1.3 Active Motif Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Active Motif Epigenetics NGS Service Product Portfolio
- 6.1.5 Active Motif Recent Developments
- 6.2 Agilent
- 6.2.1 Agilent Company Information
- 6.2.2 Agilent Business Overview
- 6.2.3 Agilent Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Agilent Epigenetics NGS Service Product Portfolio
- 6.2.5 Agilent Recent Developments
- 6.3 Zymo Research
- 6.3.1 Zymo Research Company Information
- 6.3.2 Zymo Research Business Overview
- 6.3.3 Zymo Research Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Zymo Research Epigenetics NGS Service Product Portfolio
- 6.3.5 Zymo Research Recent Developments
- 6.4 Celemics
- 6.4.1 Celemics Company Information
- 6.4.2 Celemics Business Overview
- 6.4.3 Celemics Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Celemics Epigenetics NGS Service Product Portfolio
- 6.4.5 Celemics Recent Developments
- 6.5 EpiGentek
- 6.5.1 EpiGentek Company Information
- 6.5.2 EpiGentek Business Overview
- 6.5.3 EpiGentek Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 EpiGentek Epigenetics NGS Service Product Portfolio
- 6.5.5 EpiGentek Recent Developments
- 6.6 GENEWIZ from Azenta
- 6.6.1 GENEWIZ from Azenta Company Information
- 6.6.2 GENEWIZ from Azenta Business Overview
- 6.6.3 GENEWIZ from Azenta Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 GENEWIZ from Azenta Epigenetics NGS Service Product Portfolio
- 6.6.5 GENEWIZ from Azenta Recent Developments
- 6.7 Thermo Fisher Scientific
- 6.7.1 Thermo Fisher Scientific Company Information
- 6.7.2 Thermo Fisher Scientific Business Overview
- 6.7.3 Thermo Fisher Scientific Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Thermo Fisher Scientific Epigenetics NGS Service Product Portfolio
- 6.7.5 Thermo Fisher Scientific Recent Developments
- 6.8 GenomeScan
- 6.8.1 GenomeScan Company Information
- 6.8.2 GenomeScan Business Overview
- 6.8.3 GenomeScan Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 GenomeScan Epigenetics NGS Service Product Portfolio
- 6.8.5 GenomeScan Recent Developments
- 6.9 Hologic Diagenode
- 6.9.1 Hologic Diagenode Company Information
- 6.9.2 Hologic Diagenode Business Overview
- 6.9.3 Hologic Diagenode Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Hologic Diagenode Epigenetics NGS Service Product Portfolio
- 6.9.5 Hologic Diagenode Recent Developments
- 6.10 Illumina
- 6.10.1 Illumina Company Information
- 6.10.2 Illumina Business Overview
- 6.10.3 Illumina Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Illumina Epigenetics NGS Service Product Portfolio
- 6.10.5 Illumina Recent Developments
- 6.11 Macrogen
- 6.11.1 Macrogen Company Information
- 6.11.2 Macrogen Business Overview
- 6.11.3 Macrogen Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Macrogen Epigenetics NGS Service Product Portfolio
- 6.11.5 Macrogen Recent Developments
- 6.12 Novogene
- 6.12.1 Novogene Company Information
- 6.12.2 Novogene Business Overview
- 6.12.3 Novogene Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Novogene Epigenetics NGS Service Product Portfolio
- 6.12.5 Novogene Recent Developments
- 6.13 Roche Sequencing Solutions
- 6.13.1 Roche Sequencing Solutions Company Information
- 6.13.2 Roche Sequencing Solutions Business Overview
- 6.13.3 Roche Sequencing Solutions Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Roche Sequencing Solutions Epigenetics NGS Service Product Portfolio
- 6.13.5 Roche Sequencing Solutions Recent Developments
- 6.14 SeqMatic
- 6.14.1 SeqMatic Company Information
- 6.14.2 SeqMatic Business Overview
- 6.14.3 SeqMatic Epigenetics NGS Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 SeqMatic Epigenetics NGS Service Product Portfolio
- 6.14.5 SeqMatic Recent Developments
7 North America
- 7.1 North America Epigenetics NGS Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Epigenetics NGS Service Market Size by Country (2021-2026)
- 7.3 North America Epigenetics NGS Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Epigenetics NGS Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Epigenetics NGS Service Market Size by Country (2021-2026)
- 8.3 Europe Epigenetics NGS Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Epigenetics NGS Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Epigenetics NGS Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Epigenetics NGS Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Epigenetics NGS Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Epigenetics NGS Service Market Size by Country (2021-2026)
- 10.3 South America Epigenetics NGS Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Epigenetics NGS Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Epigenetics NGS Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Epigenetics NGS Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst